1txi: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1txi.png|left|200px]] | [[Image:1txi.png|left|200px]] | ||
{{STRUCTURE_1txi| PDB=1txi | SCENE= }} | {{STRUCTURE_1txi| PDB=1txi | SCENE= }} | ||
===Crystal structure of the vdr ligand binding domain complexed to TX522=== | ===Crystal structure of the vdr ligand binding domain complexed to TX522=== | ||
{{ABSTRACT_PUBMED_15728261}} | {{ABSTRACT_PUBMED_15728261}} | ||
==About this Structure== | ==About this Structure== | ||
[[1txi]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1TXI OCA]. | |||
==See Also== | |||
*[[Vitamin D receptor|Vitamin D receptor]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:015728261</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Moras, D.]] | [[Category: Moras, D.]] | ||
[[Category: Rochel, N.]] | [[Category: Rochel, N.]] | ||
[[Category: Alpha-helical sandwich]] | [[Category: Alpha-helical sandwich]] | ||
[[Category: Gene regulation]] | |||
[[Category: Nuclear receptor]] | [[Category: Nuclear receptor]] | ||
[[Category: Transcription regulation]] | [[Category: Transcription regulation]] | ||
[[Category: Tx522 complex]] | [[Category: Tx522 complex]] | ||
[[Category: Vdr ligand binding domain]] | [[Category: Vdr ligand binding domain]] | ||
Revision as of 15:20, 20 October 2012
Crystal structure of the vdr ligand binding domain complexed to TX522
Template:ABSTRACT PUBMED 15728261
About this Structure
1txi is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Eelen G, Verlinden L, Rochel N, Claessens F, De Clercq P, Vandewalle M, Tocchini-Valentini G, Moras D, Bouillon R, Verstuyf A. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction. Mol Pharmacol. 2005 May;67(5):1566-73. Epub 2005 Feb 22. PMID:15728261 doi:10.1124/mol.104.008730
